South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec

South Africa's Biovac Institute will start making Pfizer-BioNTech's , COVID-19 vaccine early next year after receiving the drug substance from Europe, a Pfizer executive said on Monday.

Related Keywords

Cape Town ,Western Cape ,South Africa ,India ,Kigali ,W09 ,Rwanda ,Clement Uwiringiyimana ,Joe Biden ,Pfizer ,Thomson Reuters Trust Principles ,World Trade Organization ,Africa Biovac Institute ,Reuters ,Biovac Institute ,Cape Town Based Biovac ,Middle East ,Estelle Shirbon Writing ,Alexander Winning ,Thomson Reuters Trust ,M 28q ,Biodrg ,Cmpny ,Covid ,Gen ,Genhlt ,Hea ,Heca ,Humdis ,Infdis ,Intag ,Medst ,Mrch ,Moms ,Phag08 ,Phar ,Phar08 ,Phar1 ,Phmr ,Pxp ,Sci ,Un1 ,Vaccin ,Gaza ,Ceeu ,Weu ,Gamers ,Afr ,Us ,Europ ,Safr ,Ezc ,Namer ,Dude ,Emrg ,Topnws ,Topcmb ,